Tislelizumab
Tislelizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Tislelizumab is under investigation in clinical trial NCT02660034 (The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Subjects With Advanced Solid Tumors).
| Trade Name | Tislelizumab |
| Generic | Tislelizumab |
| Tislelizumab Other Names | Tislelizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Tislelizumab
